Literature DB >> 8691238

Dopamine transporters decrease with age.

N D Volkow1, Y S Ding, J S Fowler, G J Wang, J Logan, S J Gatley, R Hitzemann, G Smith, S D Fields, R Gur.   

Abstract

UNLABELLED: Postmortem studies have documented degeneration of dopamine cells with age, but the changes that occur in healthy aging individuals is less clear. The purpose of this study was to evaluate the extent to which age-induced changes in dopamine transporters occur in subjects with no evidence of motor impairment.
METHODS: We evaluated 23 right-handed healthy volunteers (age range 20-74 yr) using PET and [11C]d-threo-methylphenidate. The ratio of the distribution volume for [11C]d-threo-methylphenidate in striatum to that in cerebellum was used as model parameter for dopamine transporter availability (Bmax/Kd + 1).
RESULTS: Dopamine transporter availability was significantly lower in subjects > 40 yr of age than in those < 40 yr. Estimates of dopamine transporter availability showed a significant negative correlation with age both for the putamen (r = -0.72, p < 0.0001) and the caudate (r = -0.74, p < 0.0001). Dopamine transporter availability was higher in the left than in the right putamen but did not differ between the left and right caudate.
CONCLUSION: This study documents a 6.6% decrease per decade of life in striatal dopamine transporters of healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691238

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  75 in total

1.  Cluster C personality disorder has no independent effect on striatal dopamine transporter densities in major depression.

Authors:  T Laasonen-Balk; H Viinamäki; J Kuikka; M Husso-Saastamoinen; J Lehtonen; P Halonen; J Tiihonen
Journal:  Psychopharmacology (Berl)       Date:  2001-04       Impact factor: 4.530

2.  Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity.

Authors:  Anna Rieckmann; Trey Hedden; Alayna P Younger; Reisa A Sperling; Keith A Johnson; Randy L Buckner
Journal:  Hum Brain Mapp       Date:  2015-11-06       Impact factor: 5.038

Review 3.  Cognitive aging and Alzheimer's disease.

Authors:  R Vandenberghe; J Tournoy
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 4.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

5.  Is getting older all that rewarding?

Authors:  Dean F Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

Review 6.  Neurobiology of cognitive aging: insights from imaging genetics.

Authors:  Venkata S Mattay; Terry E Goldberg; Fabio Sambataro; Daniel R Weinberger
Journal:  Biol Psychol       Date:  2008-04-11       Impact factor: 3.251

7.  Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.

Authors:  Corinde E Wiers; Falk W Lohoff; Jisoo Lee; Christine Muench; Clara Freeman; Amna Zehra; Stefano Marenco; Barbara K Lipska; Pavan K Auluck; Ningping Feng; Hui Sun; David Goldman; James M Swanson; Gene-Jack Wang; Nora D Volkow
Journal:  Eur J Neurosci       Date:  2018-08       Impact factor: 3.386

8.  Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson's disease: a correlation study.

Authors:  Estelle Dellapina; Jean Pellaprat; Djilali Adel; Jerome Llido; Estelle Harroch; Jean Baptiste Martini; Aurélie Kas; Anne Sophie Salabert; Fabienne Ory-Magne; Pierre Payoux; Christine Brefel-Courbon
Journal:  J Neural Transm (Vienna)       Date:  2019-01-31       Impact factor: 3.575

9.  Association of liking and reinforcing value with children's physical activity.

Authors:  James N Roemmich; Jacob E Barkley; Christina L Lobarinas; Jamee H Foster; Tressa M White; Leonard H Epstein
Journal:  Physiol Behav       Date:  2008-01-14

10.  Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder.

Authors:  Feng Liu; Haruka Minami; Raul R Silva
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.